Related Experiment Video
Updated: Mar 10, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Use of Low-Value Pediatric Services Among the Commercially Insured
Kao-Ping Chua1,2, Aaron L Schwartz3, Anna Volerman4,5
1Sections of Academic Pediatrics, and kchua@peds.bsd.uchicago.edu.
Insights
At least 1 in 10 children received low-value pediatric services in 2014, costing millions. Developing claims-based measures is crucial for reducing potentially harmful care for children.
Area of Science:
- Pediatric healthcare utilization and quality measurement.
- Health services research.
- Evidence-based medicine implementation.
Background:
- Developing claims-based measures for "low-value" pediatric services is essential for reducing potentially harmful care.
- Few such validated measures currently exist, hindering intervention efforts.
Purpose of the Study:
- To develop and apply novel claims-based measures for identifying low-value pediatric services.
- To estimate the prevalence and cost of low-value pediatric service utilization in commercially insured US children.
Main Methods:
- Developed claims-based measures for 20 identified low-value pediatric services.
- Analyzed claims data from 4.4 million commercially insured US children (2014 Truven MarketScan database).
- Calculated the proportion of children receiving at least one low-value service and associated costs, using both narrow and broad measure specifications.
Main Results:
- Using narrow measures, 9.6% of children received at least one low-value service, totaling $27.0 million in spending ($9.2 million out-of-pocket).
- Using broad measures, 14.0% of children received at least one low-value service.
- Results demonstrate significant variation based on measure specification.
Conclusions:
- A novel set of claims-based measures indicates that at least 1 in 10 children received low-value pediatric services in 2014.
- Estimates of low-value pediatric service use are sensitive to the specific measures employed.
- These findings highlight the need for robust measures to guide interventions aimed at improving pediatric care quality.
Background:
Claims-based measures of "low-value" pediatric services could facilitate the implementation of interventions to reduce the provision of potentially harmful services to children. However, few such measures have been developed.
Methods:
We developed claims-based measures of 20 services that typically do not improve child health according to evidence-based guidelines (eg, cough and cold medicines). Using these measures and claims from 4.4 million commercially insured US children in the 2014 Truven MarketScan Commercial Claims and Encounters database, we calculated the proportion of children who received at least 1 low-value pediatric service during the year, as well as total and out-of-pocket spending on these services. We report estimates based on "narrow" measures designed to only capture instances of service use that were low-value. To assess the sensitivity of results to measure specification, we also reported estimates based on "broad measures" designed to capture most instances of service use that were low-value.
Results:
According to the narrow measures, 9.6% of children in our sample received at least 1 of the 20 low-value services during the year, resulting in $27.0 million in spending, of which $9.2 million was paid out-of-pocket (33.9%). According to the broad measures, 14.0% of children in our sample received at least 1 of the 20 low-value services during the year.
Conclusions:
According to a novel set of claims-based measures, at least 1 in 10 children in our sample received low-value pediatric services during 2014. Estimates of low-value pediatric service use may vary substantially with measure specification.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...